forecast

GLP-1s Could Expand Surgical Eligibility

If GLP-1 drugs cause weight loss, morbidly obese patients previously judged too high-risk for other surgeries could become eligible, potentially expanding the addressable market for robotic surgery.

forecastpending

Speaker

Joe Thomas

Evidence Quote

“some morbidly obese patients are considered too high risk to operate on for other non-bariatric procedures.”

Source

Intuitive Surgical: Robotic Precision— Business Breakdowns
Created: 11/17/2026, 9:04:47 PM

Your notes

Loading notes...